A small introduction

About Us

Ingenion Medical Limited (“Ingenion” or the “Company”) is a privately-held, medical device company headquartered in the UK. The Company specializes in creating innovative, clinically relevant, and cost effective solutions to problems of urinary flow and control.

2013

Ingenion Medical Limited Founded In The UK

2014

Clinical β-test of 1st Gen. Device

2018

Further Patient Data Gathered Through Studies

2019

International PCT Patent Filing

Let us introduce ourselves

Our Board of Directors

Alistair Taylor (Chairman)

Taylor is the chairman of IOFIX Ltd, Fen EP Ltd, & Arterius Ltd. He is also the NED of OR Productivity and Surgical Innovations. His previous positions include CEO of Biocompatibles International and President Schneider Worldwide Division of Pfizer Hospital Products.

Barry Clare (NED)

Clare is the former main board director of Boots Company plc and chairman of Healthcare Brands International and Betapharm. Chairman of Vantage Diagnostics Ltd, Lichtwer Pharma  AG. and Evgen Pharma Ltd. Chairman of University Hospital of South  Manchester Foundation Trust.

Michael Erlich (NED)

An NJIT Associate Professor. Member of the NY Angels and co-directs the New Jersey Innovation Acceleration Center

Sergio Rothstein (NED)

Rothstein was an independent practicing psychologist from 1972 – 2009. Managing partner of Marsid Realty Co. Was one of the four founders of the original business Urovalve,  Inc. and led the subsequent formation of Ingenion Medical Limited.

Meet Our Team

Senior Management

Edward Cappabianca (CEO)

Experienced investment banker who has also served as CEO of two early-stage life science companies. Has raised over US$2 billion in a range of financings from private & public equity to private debt and grant funding.

Zia Mursaleen (CFO)

Mursaleen is qualified as a chartered accountant with Deloitte, where he worked for 10 years. Director of Corporate Finance and Finance Director of the Public Houses Division of Ascot Holdings.

Ronald L. Bracken (Advisor)

Bracken was formerly VP R&D, CR Bard, CR Bard Medical Division. Currently Principal at Paladin Biomedical Consultants, LLC

Jeremy Russell (Advisor)

CEO of OR Productivity plc. Formerly R&D Director Smiths Medical International. Technical Director at Biocompatibles International

A novel innovation

CymActive™ Bladder Management System

Our CymActive™ Bladder Management System has the potential to revolutionize treatment for male patients who currently require catheters.

A novel solution

FolEase™ Catheter with Inserter System

Our FolEase™ Catheter with Inserter System offers patients an improved experience compared with traditional Foley or intermittent catheters.